Novartis appoints new comms head; Jerome Bettis and Sanofi want to know your 'AQ';

> Novartis ($NVS) has appointed Michael Willi as its group head of communications. More

> Four alcoholism meds worked to reduce addiction, a study found, which could dispel skepticism and spur greater use of the drugs. Report

> Amgen ($AMGN) is honoring four cancer survivors as part of its "Breakaway from Cancer" initiative. Release

> Novartis UK has launched a new mobile app that allows multiple sclerosis patients to track their symptoms and relapses. More

> A Johnson & Johnson ($JNJ) advertisement for a yogurt drink has been banned for exaggerating the product's health benefits. More

And Finally... Sanofi ($SNY) has signed on former NFL star Jerome Bettis to help it launch an anaphylaxis quiz during National Asthma and Allergy Awareness Month. Release

Suggested Articles

UnitedHealthcare will stop covering Descovy in PrEP in favor of Truvada, which is on track to see low-cost generic competition in September.

FDA handed NS Pharma’s Viltepso a speedy FDA nod based on the same dystrophin production data that supported two Sarepta drugs' approvals.

Rapper, actress and producer Queen Latifah—whose mother died of sclerosis-associated lung disease—joined Boehringer's "More than Scleroderma” push.